Tonix Pharmaceuticals Says FDA Set Target Action Date for Potential Fibromyalgia Drug-March 2024-www.financetom.com

Tonix Pharmaceuticals Says FDA Set Target Action Date for Potential Fibromyalgia Drug

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Tonix Pharmaceuticals Says FDA Set Target Action Date for Potential Fibromyalgia Drug

Dec 23, 2024 6:12 AM

08:59 AM EST, 12/23/2024 (MT Newswires) -- Tonix Pharmaceuticals ( TNXP ) said Monday that the US Food and Drug Administration had set a target action date of Aug. 15, 2025, for TNX-102 SL sublingual tablets to potentially treat fibromyalgia.

The company said its new drug application for TNX-102 SL, or cyclobenzaprine HCl, is supported by the results of two phase 3 trials that showed the treatment candidate significantly reduced pain compared to placebo and was well-tolerated.

Tonix's shares were falling more than 18% in recent premarket activity.

Previous page： Form 8.3 Next page： Form 8.3

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Form 8.3

Mar 11, 2026

PARIS--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION (a) Full name of discloser: DNCA FINANCE (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle...

Form 8.3

Mar 11, 2026

Endurance Gold Raises $8.3 Million Via LIFE Private Placement of Flow-Through Units and Units

Mar 11, 2026

12:56 PM EDT, 03/11/2026 (MT Newswires) -- Endurance Gold ( ENDGF ) on Wednesday said it closed a best-efforts private placement for proceeds of $8.3 million. The company sold 4.2-million flow-through units at $0.955 per FT unit for $4 million and 6.7-million hard-dollar units at $0.65 per HD unit for $4.3 million, including the additional 526,250 HD units from the...

McDonald's Insider Sold Shares Worth $862,221, According to a Recent SEC Filing

Mar 11, 2026

12:54 PM EDT, 03/11/2026 (MT Newswires) -- Joseph M. Erlinger, President, McDonald's USA, on March 10, 2026, sold 2,626 shares in McDonald's (MCD) for $862,221. Following the Form 4 filing with the SEC, Erlinger has control over a total of 8,733 common shares of the company, with 8,733 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/63908/000168580026000005/xslF345X05/form4.xml Price: 323.86, Change: -4.08, Percent Change:...